MedPath

Effect of tamsulosin on nightmares

Not Applicable
Conditions
ightmare disorder.
Nightmares
Registration Number
IRCT201412163106N21
Lead Sponsor
Islamic azad university of pharmaceutical sciense
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

1. Nightmare disorder Patients who are interested in treatment and earn necessary score on disturbing dreams and nightmares severity index (DDNSI) questionnaire; 2. No concomitant disease that limit the use of tamsulosin; 3. Quality of life and sleep impairment make drug therapy beneficial; 4. No concomitant drug therapy which have life threatening interactions with tamsulosin
Exclusion criteria: 1. Patients who have a low blood pressure occurrence serious side effect; 2. Patients who are not interested for treatment; 3. Patients who have sensitivity to sulfa drugs and tamsulosin or ingredients; 4. Occurrence of serious side effect like severe orthostatic hypotension; 5. Patients with cardiovascolar disease.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction or totally disappearing disturbing dreams and nightmares. Timepoint: Weeks: 0, 4, 6 and 10. Method of measurement: Disturbing dreams and nightmares severity index questionnaire and interviewing about sleep improvement.
Secondary Outcome Measures
NameTimeMethod
Reported side effectd-hypotension. Timepoint: Weeks: 0, 4, 6 and 10. Method of measurement: Blood pressure monitoring.
© Copyright 2025. All Rights Reserved by MedPath